Porfidia, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 2.422
AS - Asia 1.544
EU - Europa 1.224
SA - Sud America 330
AF - Africa 43
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.571
Nazione #
US - Stati Uniti d'America 2.357
SG - Singapore 736
CN - Cina 302
BR - Brasile 266
IT - Italia 246
SE - Svezia 218
VN - Vietnam 192
PL - Polonia 162
DE - Germania 155
FR - Francia 125
IE - Irlanda 61
GB - Regno Unito 56
IN - India 50
ID - Indonesia 46
FI - Finlandia 43
JP - Giappone 43
BD - Bangladesh 40
UA - Ucraina 39
HK - Hong Kong 38
CA - Canada 35
AR - Argentina 30
RU - Federazione Russa 26
MX - Messico 21
ZA - Sudafrica 21
IQ - Iraq 18
ES - Italia 14
NL - Olanda 14
BE - Belgio 13
AT - Austria 12
TR - Turchia 12
KR - Corea 11
PK - Pakistan 11
EC - Ecuador 10
LT - Lituania 8
GR - Grecia 7
MA - Marocco 7
CO - Colombia 6
UZ - Uzbekistan 6
VE - Venezuela 6
AU - Australia 5
IR - Iran 5
PE - Perù 5
PY - Paraguay 5
CH - Svizzera 4
GE - Georgia 4
JO - Giordania 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
ET - Etiopia 3
JM - Giamaica 3
KE - Kenya 3
MY - Malesia 3
NP - Nepal 3
RO - Romania 3
SA - Arabia Saudita 3
TH - Thailandia 3
BG - Bulgaria 2
BH - Bahrain 2
CI - Costa d'Avorio 2
EU - Europa 2
HU - Ungheria 2
MD - Moldavia 2
PH - Filippine 2
AZ - Azerbaigian 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
MN - Mongolia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 5.571
Città #
Singapore 430
Chandler 274
Ashburn 271
Dallas 259
San Jose 241
Warsaw 158
Fairfield 108
Beijing 77
Ho Chi Minh City 70
Rome 64
Dublin 60
Los Angeles 53
New York 52
Woodbridge 51
Wilmington 48
Tokyo 43
Houston 42
Seattle 40
Hefei 39
Lauterbourg 38
The Dalles 38
Ann Arbor 37
Hanoi 36
Jakarta 36
Marseille 36
Milan 36
Cambridge 34
Hong Kong 31
San Mateo 31
Boston 29
Boardman 26
Frankfurt am Main 26
São Paulo 24
Council Bluffs 22
Helsinki 22
Princeton 22
Chicago 19
Moscow 19
Jacksonville 18
Munich 17
Santa Clara 17
Nanjing 15
Brussels 13
Kent 13
London 13
Montreal 13
St Louis 13
Brooklyn 11
Da Nang 11
Johannesburg 11
Mexico City 11
Nuremberg 11
Seoul 11
Buffalo 10
Hyderabad 10
Paris 10
Bergamo 9
Dearborn 9
Orem 9
Toronto 9
Turku 9
Baghdad 8
Bremen 8
Cattolica 8
Denver 8
Falkenstein 8
Naples 8
Washington 8
Zhengzhou 8
Athens 7
Augusta 7
Detroit 7
Düsseldorf 7
Fremont 7
Lawrence 7
Rio de Janeiro 7
Vienna 7
Belo Horizonte 6
Dong Ket 6
Haiphong 6
Lappeenranta 6
Memphis 6
Prato 6
Qingdao 6
Salvador 6
San Diego 6
Amsterdam 5
Busto Arsizio 5
Campinas 5
Hải Dương 5
Jiaxing 5
Lancaster 5
Manaus 5
Pune 5
Redwood City 5
Atlanta 4
Biên Hòa 4
Changsha 4
Columbus 4
Curitiba 4
Totale 3.454
Nome #
Microparticles Carrying Sonic Hedgehog Are Increased in Humans with Peripheral Artery Disease. 335
Differences in Clinical Presentation, Rate of Pulmonary Embolism, and Risk Factors Among Patients With Deep Vein Thrombosis in Unusual Sites. 280
Sonic hedgehog is expressed in human brain arteriovenous malformations and induces arteriovenous malformations in vivo 266
Influence of left ventricular hypertrophy on microvascular dysfunction and left ventricular remodeling after acute myocardial infarction 195
Patent foramen ovale and hypercoagulable state in the pathogenesis of acute thrombotic myocardial infarction 193
Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry 175
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis 173
Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis 165
Venous thromboembolism in COVID-19 patients 155
Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in Apical Ballooning or Tako-Tsubo Syndrome 151
Antithrombotic therapy and intracranial bleeding in subjects with sporadic brain arteriovenous malformations: preliminary results from a retrospective study. 147
Pulmonary Embolism in COVID-19 Patients: Which Diagnostic Algorithm Should We Use? 146
Polycythemia vera. 137
Upper extremity deep vein thrombosis treated with direct oral anticoagulants: a multi-center real world experience 134
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 133
Anticoagulant treatment for upper extremity deep vein thrombosis: A systematic review and meta-analysis 131
Safety of Anticoagulant Treatment in Patients With Splanchnic Vein Thrombosis and History of Portal Hypertension–Related Bleeding 127
Controversies in venous thromboembolism: the unique case of isolated distal deep vein thrombosis 127
Distribution of Cerebrovascular Phenotypes According to Variants of the ENG and ACVRL1 Genes in Subjects with Hereditary Hemorrhagic Telangiectasia 126
Safety of Anticoagulant Treatment in Patients With Splanchnic Vein Thrombosis and History of Portal Hypertension–Related Bleeding 119
SARS-CoV-2 infection in a highly experienced person living with HIV 118
Clinical Correlates of In-Hospital Mortality in Patients Undergoing Inferior Vena Cava Filter Placement for Acute Deep Vein Thrombosis 110
Low-Dose Rivaroxaban to Prevent Recurrences of Venous Thromboembolism in Cancer: A Real-Life Experience with a Focus on Female Patients 107
A Single Center Retrospective Cohort Study Comparing Different Anticoagulants for the Treatment of Catheter-Related Thrombosis of the Upper Extremities in Women With Gynecologic and Breast Cancer 107
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience 107
Correction to: Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines (Journal of Thrombosis and Thrombolysis, (2020), 50, 1, (68-71), 10.1007/s11239-020-02125-4) 107
Gut dysbiosis-related thrombosis in inflammatory bowel disease: Potential disease mechanisms and emerging therapeutic strategies 105
Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies 105
Safety of Anticoagulant Treatment in Patients With Splanchnic Vein Thrombosis and History of Portal Hypertension–Related Bleeding 102
Follow-up management of patients receiving direct oral anticoagulants 100
CT pulmonary angiography for the diagnosis of pulmonary embolism in patients with COVID-19: When, why, and for whom? 100
Second wave of the COVID-19 pandemic: D-dimer levels are not so high anymore 99
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis 98
Acute Right Ventricular Heart Failure: An Uncommon Case of Thyrotoxicosis 96
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis 92
High-dose versus low-dose venous thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis 91
Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis 91
No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19 89
Prevalence of pulmonary embolism on hospital admission in COVID-19 patients: Is there a role for pre-test probability scores and home treatment? 89
Major Bleeding Risk Assessment in Patients with Cancer-Associated Venous Thromboembolism Treated with DOACs: Data from a Multicenter Cohort 87
Prophylaxis against venous thromboembolism in patients with cancer 86
Sonic hedgehog is expressed in human brain arteriovenous malformations and induces arteriovenous malformations in vivo 79
Major Bleeding Risk Assessment in Patients with Cancer-Associated Venous Thromboembolism Treated with DOACs: Data from a Multicenter Cohort 69
Totale 5.649
Categoria #
all - tutte 21.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022356 33 20 11 23 22 15 9 49 9 20 60 85
2022/2023688 83 105 49 89 49 69 51 67 81 9 22 14
2023/2024388 20 80 18 36 27 57 43 7 8 10 26 56
2024/2025806 12 17 54 16 62 37 37 47 98 134 172 120
2025/20262.614 289 81 401 285 372 122 456 90 158 180 152 28
Totale 5.649